Article Details

Thermo Fisher (TMO)-AstraZeneca to Co-Develop NGS-Based CDx - September 6, 2021 - Zacks.com

Retrieved on: 2021-09-06 14:02:52

Tags for this article:

Click the tags to see associated articles and topics

Thermo Fisher (TMO)-AstraZeneca to Co-Develop NGS-Based CDx - September 6, 2021 - Zacks.com. View article details on HISWAI: https://www.zacks.com/stock/news/1792392/thermo-fisher-tmo-astrazeneca-to-co-develop-ngs-based-cdx

Excerpt

Over 90% of AstraZeneca's clinical pipelines, including key areas such as oncology, cardiovascular and renal, metabolic, and respiratory disease are targeted ...

Article found on: www.zacks.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up